Cancer Prevention: Stories For Change In Hispanic Community
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 22-008177
Sponsor Protocol Number: 22-008177
About this study
This study is a process evaluation of a digital storytelling (DST) intervention. Because the DST intervention has not yet been developed, it is appropriate to use qualitative methods to assess the process.
This study will recruit gifted storytellers for a digital storytelling intervention on breast, cervical, and colorectal cancer. A digital storytelling intervention will be developed to improve breast, cervical, and colorectal cancer screening rates among Hispanic, Spanish speaking individuals. Additionally, to conduct a qualitative assessment of the digital storytelling workshop.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Hispanic adults (age 18 or older).
- Speak Spanish fluently.
- Identify as a survivor or co-survivor of breast, cervical, or colorectal cancer.
- Have received all the recommended COVID-19 vaccinations for their age group (we will be in close quarters during the DST workshop and want to protect any participants who may be immunocompromised after receiving cancer treatment).
Exclusion Criteria:
- People younger than 18 years old.
- Non-Hispanic individuals.
- Hispanic individuals who do NOT speak Spanish.
- Individuals who do NOT identify as a survivor or co-survivor of breast, cervical, or colorectal cancer.
- Individuals who have not received a COVID-19 vaccination.
Eligibility last updated 8/2/22. Questions regarding updates should be directed to the study team contact
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Irene Sia, M.D., M.S. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available